Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026

PG vs JNJ: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

JNJ Wins Head-to-Head Institutional Verdict (5–1 across 6 Pillars · 5–5 Matrix Metrics)

JNJ Overall Winner 6-Pillar Tally: PG 1 – 5 JNJ Matrix Metrics: PG 5 – 5 JNJ

As of Nov 20, 2026, Johnson & Johnson (JNJ) is the stronger overall head-to-head candidate over Procter & Gamble Company (PG) in the Tradestie Institutional Equity Comparison Engine, winning 5–5 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). PG carries a Unified Composite Score of 33.6/100 (SELL) at $169.37 (24.0x Forward P/E, 24.9% operating margin), whereas JNJ carries 57.8/100 (HOLD) at $270.47 (23.3x Forward P/E, 26.6% operating margin).

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About PG vs JNJ
PG NYSE
Procter & Gamble Company
Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics
$169.37
+0.91% 1D
Market Cap $389.0B
TTM Revenue $87.9B
Forward P/E 24.0x
Beta / 30D Vol 0.02β · 21% Vol
Unified Composite Score
33.6 / 100 SELL
Tech 19.0 Fund 38.0 Flow 56.0 Mom 40.0
Weinstein Technical Phase Markup · Hold / add on dips
Price above SMA50, rising 50-day trend (5.7% over 20 days), RSI 61
RSI-14: 61.0 · SMA20: $165.99 · SMA50: $156.84
JNJ NYSE Head-to-Head Winner
Johnson & Johnson
Pharmaceutical Preparations
$270.47
+1.25% 1D
Market Cap $643.1B
TTM Revenue $99.3B
Forward P/E 23.3x
Beta / 30D Vol -0.04β · 25% Vol
Unified Composite Score
57.8 / 100 HOLD
Tech 47.0 Fund 54.0 Flow 66.0 Mom 50.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 48
RSI-14: 48.1 · SMA20: $275.01 · SMA50: $267.43

6-Pillar Scorecard Institutional Category Breakdown (PG 1 – 5 JNJ)

Columns: Metric · PG · JNJ
1. Valuation Multiples JNJ
Forward P/E 24.0x 23.3x
Trailing P/E 25.3x 40.5x
PEG Ratio 4.38x 3.07x
EV / Revenue 4.7x 6.8x
2. Growth & Scale JNJ
Revenue Growth (YoY) +4.0% +5.9%
Earnings Growth (YoY) +0.8% -95.9%
TTM Revenue (USD) $87.9B $99.3B
Market Cap $389.0B $643.1B
3. Profitability & Quality JNJ
Gross Margin 50.6% 67.8%
Operating Margin 24.9% 26.6%
Net Profit Margin 18.2% 16.2%
Return on Equity (ROE) 29.6% 20.0%
4. Balance Sheet & Cash Flow JNJ
Cash Generation (TTM) $15.3B $19.6B
Cash Flow Margin 17.4% 19.7%
Net Cash / Leverage $23.6B Net Debt (0.71x D/E) $27.7B Net Debt (0.55x D/E)
Dividend Yield 2.52% 1.94%
5. Options & Positioning PG
Options Structure Phase SURGE CONSOLIDATION
Current IV / %ile 15.0% (12th %ile) 34.7% (45th %ile)
Put/Call OI Skew 0.59x (Call-Skewed) 0.76x (Call-Skewed)
OBV Trend / Tech Phase ACCUMULATION · Markup DISTRIBUTION · Neutral
6. R&D & Supply-Chain Moat JNJ
OpEx & R&D Intensity 25.7% of Rev ($22.6B) 41.2% of Rev ($40.9B)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Scale & Operating Efficiency Moat Scale & Operating Efficiency Moat
Supply-Chain Role Household & Personal Products Operator Drug Manufacturers - General Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: PG (5) vs JNJ (5)
Institutional Metric PG JNJ Criterion Row Edge
Market Capitalization
Scale
$389.0B $643.1B Larger Scale JNJ
Trailing P/E Ratio
Valuation
25.3x 40.5x Lower Multiple PG
Forward P/E Ratio
Valuation
24.0x 23.3x Lower Multiple JNJ
Revenue Growth (YoY)
Growth
+4.0% +5.9% Higher Growth JNJ
Operating Margin (TTM)
Profitability
24.9% 26.6% Higher Margin JNJ
Net Profit Margin
Profitability
18.2% 16.2% Higher Margin PG
Return on Equity (ROE)
Capital Efficiency
29.6% 20.0% Higher ROE PG
52-Week Range Position
Momentum
88% ($138–$174) 78% ($199–$290) Stronger Trend PG
Beta / 30D Volatility
Risk Regime
0.02β · 21% Vol -0.04β · 25% Vol Lower Realized Risk PG
Unified Institutional Score
Composite Signal
33.6 / 100 (SELL) 57.8 / 100 (HOLD) Higher Composite JNJ
Trailing 12M Revenue (USD)
Operating Scale
$87.9B $99.3B FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
50.6% 67.8% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
4.38x PEG · 4.7x EV/Rev 3.07x PEG · 6.8x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$15.3B ($23.6B Net Debt (0.71x D/E)) $19.6B ($27.7B Net Debt (0.55x D/E)) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon PG +1.21 pp
PG: +2.28% · JNJ: +1.07%
3M Horizon PG +16.47 pp
PG: +15.53% · JNJ: -0.94%
6M Horizon PG +1.84 pp
PG: +17.26% · JNJ: +15.42%
1Y Horizon JNJ +18.33 pp
PG: +15.23% · JNJ: +33.56%

Financial Trajectory Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant USD Revenue & Operating Margin (%)
Period PG Revenue JNJ Revenue PG Op. Margin JNJ Op. Margin Margin Leader
FY2019 $67.7B $82.1B 8.1% 18.4% JNJ
FY2020 $71.0B N/A 22.1% N/A PG
FY2021 $76.1B $82.6B 23.6% 17.8% PG
FY2022 $80.2B $78.7B 22.2% 26.5% JNJ
FY2023 $82.0B $85.2B 22.1% 41.3% JNJ
FY2024 $84.0B $88.8B 22.1% 15.8% PG
FY2025 $84.3B $94.2B 24.3% 28.5% JNJ
FY2026 $87.0B N/A 22.7% N/A PG

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
PG SURGE
5d in phase · OBV ACCUMULATION
Current IV 15.0%
IV Percentile 12th %ile
Put/Call OI Skew 0.59x (Call-Skewed)
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow ACCUMULATION
Exact PG Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
JNJ CONSOLIDATION
66d in phase · OBV DISTRIBUTION
Current IV 34.7%
IV Percentile 45th %ile
Put/Call OI Skew 0.76x (Call-Skewed)
IV Regime Balanced (25th–60th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow DISTRIBUTION
Exact JNJ Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
LIVE OPTIONS CHAIN · T+5 TRADING DAY HORIZON Spot $173.02 · IV 22.7%

PG vs. JNJ: Simulated 5-Day Option Payoffs & Capital Efficiency

Compare 100 shares of PG ($17,302) vs. JNJ ($28,255) against risk-defined 5-day vertical and put-wall option structures.

PG Spot $173.02 · IV 22.7%
PG Options Simulator →
5-DAY BULLISH SWING Liq A

Dec 18 $170 / $180 Bull Call Spread

Buy 1x $170C · Sell 1x $180C · 31d

Net Entry $456 Debit
T+5d @ +5% Move +$306 (+67%)
Max Risk / Buffer $456 Capped
5d Edge & Liquidity 0.9x R:R · Liq A
Simulate 5-Day Payoff →
PUT-WALL MONTHLY INCOME Liq A

Dec 18 $165 / $155 Bull Put Spread

Sell 1x $165P · Buy 1x $155P · 31d

Net Entry $114 Credit
Max Credit / Yield +$114 (+12.9% RoM)
Max Risk / Buffer -5.3% Cushion ($886 Mgn)
5d Edge & Liquidity 78% PoP · Liq A
Simulate 5-Day Payoff →
JNJ Spot $282.55 · IV 26.6%
JNJ Options Simulator →
5-DAY BULLISH SWING Liq A

Dec 18 $280 / $300 Bull Call Spread

Buy 1x $280C · Sell 1x $300C · 31d

Net Entry $742 Debit
T+5d @ +5% Move +$526 (+71%)
Max Risk / Buffer $742 Capped
5d Edge & Liquidity 1.0x R:R · Liq A
Simulate 5-Day Payoff →
PUT-WALL MONTHLY INCOME Liq A

Dec 18 $270 / $260 Bull Put Spread

Sell 1x $270P · Buy 1x $260P · 31d

Net Entry $240 Credit
Max Credit / Yield +$240 (+31.6% RoM)
Max Risk / Buffer -5.3% Cushion ($760 Mgn)
5d Edge & Liquidity 73% PoP · Liq A
Simulate 5-Day Payoff →

Simulated T+5 trading day payoffs use live option midpoints, bid-ask spread adjustments, and implied volatility skew for educational scenario modeling only — not personalized investment advice. Options involve substantial risk.

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
PG Moat Profile Scale & Operating Efficiency Moat
Household & Personal Products Operator
Competes within the Household & Personal Products value chain with $389.0B market capitalization and 24.9% operating margin.
OpEx & R&D Reinvestment 25.7% of Rev ($22.6B)
90D Engineering Disclosures 0 Published
JNJ Moat Profile Scale & Operating Efficiency Moat
Drug Manufacturers - General Operator
Competes within the Drug Manufacturers - General value chain with $643.1B market capitalization and 26.6% operating margin.
OpEx & R&D Reinvestment 41.2% of Rev ($40.9B)
90D Engineering Disclosures 0 Published

Investor FAQ PG vs JNJ Key Questions & Quantitative Answers

As of Nov 20, 2026, Johnson & Johnson (JNJ) is the stronger overall head-to-head candidate over Procter & Gamble Company (PG) in the Tradestie Institutional Equity Comparison Engine, winning 5–5 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). PG carries a Unified Composite Score of 33.6/100 (SELL) at $169.37 (24.0x Forward P/E, 24.9% operating margin), whereas JNJ carries 57.8/100 (HOLD) at $270.47 (23.3x Forward P/E, 26.6% operating margin). Technically, PG sits in a Markup phase (RSI 61.0, SURGE options structure) and JNJ sits in a Neutral phase (RSI 48.1, CONSOLIDATION options structure).

JNJ leads the Growth & Scale pillar: PG posts +4.0% YoY revenue growth and +0.8% YoY earnings growth on $87.9B TTM revenue (50.6% gross margin, 24.9% operating margin), compared with JNJ at +5.9% YoY revenue growth and -95.9% YoY earnings growth on $99.3B TTM revenue (67.8% gross margin, 26.6% operating margin). Across the 8-period historical trajectory (FY2019 to FY2026), PG cumulative revenue shifted +28.6% while JNJ shifted +14.8%. In operating R&D and SG&A reinvestment, PG deploys 25.7% of Rev ($22.6B) (0 90-day corporate R&D disclosures) versus 41.2% of Rev ($40.9B) (0 disclosures) for JNJ.

JNJ screens cheaper on headline valuation multiples. PG trades at 24.0x Forward P/E, 25.3x Trailing P/E, 4.38x PEG, and 4.7x EV/Revenue (17.4% FCF margin), whereas JNJ trades at 23.3x Forward P/E, 40.5x Trailing P/E, 3.07x PEG, and 6.8x EV/Revenue (19.7% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against PG (29.6% ROE) versus JNJ (20.0% ROE) capital efficiency.

In options market volatility and institutional positioning, PG carries 15.0% implied volatility (12th %ile, Compressed (<25th %ile)), a 0.59x (Call-Skewed) Put/Call open-interest ratio, ACCUMULATION on-balance volume, and sits in a SURGE options structure phase (0.02β · 21% Vol realized risk). By comparison, JNJ carries 34.7% implied volatility (45th %ile, Balanced (25th–60th %ile)), a 0.76x (Call-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a CONSOLIDATION options structure phase (-0.04β · 25% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.